/CNW/ - Perceiv AI, a leading AI-driven precision medicine company specializing in the development of a multimodal prognostic platform for age-related.
/PRNewswire/ - Perceiv AI announced that the company has been selected by Merck (NYSE: MRK) for the inaugural Merck Digital Sciences Studio (MDSS) cohort,.
/PRNewswire/ - Perceiv AI today announced the closing of an investment of $1.5M. Perceiv AI is a precision medicine company optimizing and de-risking clinical.
/PRNewswire/ - Perceiv Research Inc. (operating as Perceiv AI), a precision medicine company reshaping clinical trials by forecasting disease evolution, today.